Kawsar R. Talaat, MD
Johns Hopkins Bloomberg School of Public Health
3
3
3
N/A
0
2
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Herbert B Slade, MD
Healthpoint
Shared therapeutic areas:
Carl T D'Angio, MD
University of Rochester
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Novartis vaccines and Diagnostics
Novartis Vaccines
Shared therapeutic areas:
James C Eisenach, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
Lorenzo Berra, MD
Massachusetts General Hospital
Shared therapeutic areas:
James Malone, MD
Eli Lilly and Company
Shared therapeutic areas:
Jack A Yanovski, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals
Human Challenge Model Refinement With Enterotoxigenic Escherichia Coli Strain B7A
Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine
All 3 trials loaded